Irritable bowel syndrome.
Within the literature, it appears evident that neither a univariate etiologic model nor a single-agent treatment approach is sufficient to address the many diagnostic, assessment, and therapeutic challenges posed by irritable bowel syndrome (IBS). Various scientific advances have been made over the past 5 years, particularly in the areas of nonpharmacologic management of IBS. However, further collaboration between scientists and clinicians from multiple disciplines is strongly encouraged.
Turner
S M
SM
Department of Family Medicine, Oklahoma State University College of Osteopathic Medicine, 1111 W. 17th Street, Tulsa, OK 74107-1898, USA. smturne@osu-com.okstate.edu
Stewart
J E
JE
Alexopulos
J J
JJ
Hill
J S
JS
D003109:Colonic Diseases, Functional / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans